Patents by Inventor Connie HSIA

Connie HSIA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11491115
    Abstract: Nanoparticles coated with extracellular matrix (ECM) are provided, in some aspects, for the delivery of a therapeutic protein, nucleic acid, or drug. In some embodiments, the nanoparticles are delivered to a subject via inhalation or aerosol delivery. Also provided, in some aspects, are methods for treating acute lung injury comprising administering ?-Klotho (?Klotho) protein or DNA to a subject.
    Type: Grant
    Filed: July 8, 2016
    Date of Patent: November 8, 2022
    Assignee: The Board of Regents of The University of Texas System
    Inventors: Connie Hsia, Yi Hong, Orson W. Moe, Kytai Nguyen
  • Patent number: 10912791
    Abstract: Provided herein are nanoparticles comprising antisense-encoded erythropoietin receptor (RopE) alone or in combination with erythropoietin receptor (EpoR). Also provided herein are methods of treating or preventing lungs disorders comprising administering RopE alone or in combination with EpoR.
    Type: Grant
    Filed: September 11, 2017
    Date of Patent: February 9, 2021
    Assignee: The Board of Regents of the University of Texas System
    Inventors: Connie Hsia, Orson W. Moe, Kytai Nguyen
  • Publication number: 20190262376
    Abstract: Provided herein are nanoparticles comprising antisense-encoded erythropoietin receptor (RopE) alone or in combination with erythropoietin receptor (EpoR). Also provided herein are methods of treating or preventing lungs disorders comprising administering RopE alone or in combination with EpoR.
    Type: Application
    Filed: September 11, 2017
    Publication date: August 29, 2019
    Applicant: The Board of Regents of the University of Texas System
    Inventors: Connie HSIA, Orson W. MOE, Kytai NGUYEN
  • Publication number: 20180207107
    Abstract: Nanoparticles coated with extracellular matrix (ECM) are provided, in some aspects, for the delivery of a therapeutic protein, nucleic acid, or drug. In some embodiments, the nanoparticles are delivered to a subject via inhalation or aerosol delivery. Also provided, in some aspects, are methods for treating acute lung injury comprising administering ?-Klotho (?Klotho) protein or DNA to a subject.
    Type: Application
    Filed: July 8, 2016
    Publication date: July 26, 2018
    Applicant: The Board of Regents of the University of Texas System
    Inventors: Connie HSIA, Yi HONG, Orson W. MOE, Kytai NGUYEN